A novel treatment for amyotrophic lateral sclerosis (ALS) that targets brain cell energy production to promote remyelination showed signs of efficacy in a phase 2 trial, though it did not meet its primary endpoint, which was the change in the summated motor unit index (MUNIX) from baseline to week 36. The drug, CNM-Au8, is being developed by […]

Sigyn’s Jeremy Farrell is preparing to issue more shares even as some companies are shying away from tapping equity amid rising stock market volatility. Sigyn Therapeutic’s new CFO is betting the medical technology company can overcome stock market volatility to unlock a longer-term financing runway through a shelf registration and an uplisting to the Nasdaq exchange […]

Need to Know: Social media can be a powerful tool to directly advertise ongoing clinical trials to target patients, but such an unregulated space increases the risk of companies being exposed of negative or untrue comments. While having an inhouse press team allows a pharma company to have a dedicated crew for its communication plans, […]